UffTeriAda Logo

WHO endorses Ebola Vaccine that’s up to 100% effective

Ebola Vaccine

  • A major trial has shown a prototype vaccine to be “very effective” against the deadly Ebola virus, according to the World Health Organization that co-funded the study.
  • Not one of the 6,000 people in Guinea who were given the test vaccine last year contracted the disease within 10 days,
  • WHO said on Friday announcing the final results, without elaborating on what happens after 10 days as Ebola has an incubation period of up to three weeks.
  • In a comparison group of similar size, not given the vaccine, there were 23 cases in the 10 days, researchers reported in The Lancet medical journal.
  • “If we compare zero to 23, this strongly suggests that the vaccine is very effective, that it could be up to 100 percent effective,” Marie-Paule Kieny, WHO’s assistant director-general and lead author of the study, told AFP news agency.

Ebola Vaccine

  • Her team of three dozen researchers calculated a 90 percent likelihood during a full-fledged epidemic that the vaccine, known as  rVSV-ZEBOV, would work in more than 80 percent of cases.
  • Ebola Vaccine name :  rVSV-ZEBOV
  • The new vaccine – initially developed in Canada by public health authorities before being taken over by pharmaceutical giant Merck – is scheduled to be submitted to health authorities in the United States and Europe sometime next year under a fast-track approval process.
  • “We may have a vaccine which is registered in 2018,” Kieny said at a press conference on Thursday, noting that the standard approval process for a new drug takes a decade, if not more.
READ  Pakistan Train Accident : 16 killed, 40 injured as trains collide in Pakistan

Major Questions about Ebola Virus :

  • However, it is still unknown how long the efficacy of an inoculation lasts.
  • “With the Canadian Merck vaccine, you have a protection very early after vaccination, but we don’t know if it will last after six months,” Kieny said.
  • Also, initial tests last year did not include children, while the most recent trials covered those over six years old.
  • Of the more than 6,000 people injected with the Ebola vaccine only two showed serious adverse effects, the study reported. Both recovered fully.
  • But it is still unknown if the vaccine is safe for children six and under, pregnant women, or people with the Aids virus – all groups that were excluded from the most recent trials.
READ  Indian Origin Lawyer Nathan Desai : Houston Shooting

 

Ebola Vaccine

  • Other Ebola vaccines under development – some of which have been tested in humans – could prove more effective over a longer period.
  • British firm Glaxosmithkline and Johnson & Johnson, based in the US,  each have experimental products in the pipeline.
  • China and Russia have also developed vaccines, with the Russian one having just finished the second phase of three-step clinical trials.
  • Some of these vaccines require two doses three weeks apart, and may confer a longer immunity.
  • “That might be better suited to immunise health workers in advance of an outbreak,” Kieny said.

 

What is Ebola?

  • Ebola, also known as Ebola hemorrhagic fever or Ebola viral disease, is a rare and deadly illness caused by one of the strains of Ebola virus.
  • This viral agent is regarded as a prototype pathogen of viral hemorrhagic fever, with high fatality rates in humans and primates.
  • The natural reservoir of Ebola virus remains unknown, although bats seem to be the most likely reservoir.
  • Infections with Ebola virus are characterized by immune suppression and a severe inflammatory response that damages vascular, coagulation and immune systems, subsequently resulting in bleeding, multiorgan failure and shock.
  • Human-to-human transmission can lead to outbreaks, which are often initiated by a single introduction from the reservoir in nature or another end host.
  • Despite important scientific achievements on the biology and pathogenesis of Ebola virus during the past two decades, exact virulence factors and host responses are yet to be determined.
  • Those unanswered questions have hampered the development of proper treatment methods and vaccines, which is a reason why there are currently no licensed prophylaxis or treatment measures for this infection.

THANKS FOR READING !!

 

READ  NPCI Lucky Draw Contest - Do Digital Transactions and Win Rs 125 Crore

TagsEbola Vaccine found,what is ebola, Ebola Vaccine by WHO,WHO,ebola, Ebola Virus,ebola vaccine status,ebola vaccine 2016,ebola vaccine news,ebola vaccine found,has ebola vaccine been found


Leave a Reply